• LAST PRICE
    11.5800
  • TODAY'S CHANGE (%)
    Trending Down-0.0600 (-0.5155%)
  • Bid / Lots
    11.0000/ 3
  • Ask / Lots
    15.0000/ 1
  • Open / Previous Close
    11.6800 / 11.6400
  • Day Range
    Low 11.4500
    High 11.9400
  • 52 Week Range
    Low 7.3000
    High 15.8900
  • Volume
    136,611
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Tuesday's close: 11.64
TimeVolumeCGEM
09:32 ET51711.53
09:33 ET10011.48
09:42 ET10011.74
09:50 ET10011.74
09:51 ET10011.75
09:53 ET50011.745
09:57 ET20011.94
10:06 ET10011.91
10:08 ET10011.81
10:11 ET70011.84
10:20 ET140011.86
10:26 ET30011.9
10:27 ET20011.875
10:29 ET180011.85
10:36 ET140411.88
10:40 ET10011.835
10:44 ET21511.75
10:47 ET10011.84
10:54 ET20011.72
11:00 ET10011.645
11:07 ET40011.71
11:14 ET10011.77
11:20 ET20011.77
11:21 ET20011.77
11:34 ET24011.785
11:41 ET10011.785
11:45 ET10011.81
11:50 ET20011.89
11:52 ET78611.86
11:54 ET13411.88
11:57 ET20011.8
12:01 ET28811.82
12:06 ET80011.72
12:08 ET20011.72
12:10 ET10011.725
12:12 ET10011.71
12:17 ET30011.715
12:19 ET100011.72
12:37 ET30011.7
12:39 ET20011.655
12:44 ET10011.685
12:51 ET10011.7
12:57 ET190011.68
01:00 ET20011.695
01:02 ET64611.6838
01:06 ET20011.695
01:15 ET60011.68
01:33 ET10011.665
01:49 ET40011.64
01:51 ET90011.625
01:54 ET80011.5
01:56 ET60011.5
01:58 ET80011.46
02:00 ET152811.545
02:02 ET80011.47
02:05 ET20011.45
02:07 ET110011.56
02:09 ET20011.535
02:14 ET87711.595
02:16 ET20011.61
02:18 ET20011.59
02:20 ET30011.59
02:21 ET30211.64
02:23 ET10011.59
02:25 ET40011.65
02:32 ET130011.57
02:34 ET20011.52
02:38 ET50011.61
02:39 ET30011.63
02:41 ET70011.7
02:43 ET10011.65
02:45 ET20011.655
02:48 ET70011.74
02:50 ET20011.69
02:54 ET436311.71
02:56 ET10011.71
02:57 ET10011.715
02:59 ET60011.7
03:03 ET62011.72
03:06 ET130011.73
03:08 ET230011.7
03:10 ET10011.72
03:15 ET70011.65
03:17 ET10011.69
03:19 ET20011.7
03:21 ET40411.7
03:24 ET20011.71
03:26 ET10011.7
03:28 ET10011.71
03:30 ET160011.72
03:33 ET40011.695
03:35 ET110011.71
03:37 ET197611.71
03:39 ET40011.68
03:42 ET10011.72
03:44 ET100011.705
03:48 ET53811.69
03:50 ET49711.65
03:51 ET30011.605
03:53 ET110011.55
03:55 ET80011.53
03:57 ET180011.54
04:00 ET194211.58
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCGEM
Cullinan Oncology Inc
457.7M
5.3x
---
United StatesATRA
Atara Biotherapeutics Inc
481.0M
-2.1x
---
United StatesABUS
Arbutus Biopharma Corp
471.0M
-6.0x
---
United StatesCRBU
Caribou Biosciences Inc
439.8M
-5.0x
---
United StatesMESO
Mesoblast Ltd
494.3M
-5.5x
---
United StatesGHRS
GH Research PLC
462.5M
-27.4x
---
As of 2023-02-01

Company Information

Cullinan Oncology, Inc., formerly Cullinan Management, Inc. is a biopharmaceutical company. The Company is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients. The Company’s lead candidate, CLN-081 in a Phase I/IIa, is an orally available small molecule designed as an irreversible epidermal growth factor receptor (EGFR), inhibitor that is designed to selectively target cells expressing mutant EGFR variants, including EGFR exon 20 insertion (EGFRex20ins), mutations, with relative sparing of cells expressing wild type EGFR. The Company’s evaluating CLN-081 as a treatment for non-small cell lung cancer (NSCLC), in adult patients with EGFRex20ins mutations in a Phase I/IIa trial. The Company’s other product candidates include CLN-049, CLN-619, CLN-617, CLN-978, Opal and Jade.

Contact Information

Headquarters
One Main Street, Suite 1350CAMBRIDGE, MA, United States 02142
Phone
617-410-4650
Fax
302-655-5049

Executives

Independent Chairman of the Board
Anthony Rosenberg
President, Chief Executive Officer, Director
Nadim Ahmed
Co-Founder, Acting Chief Scientific Officer
Patrick Baeuerle
Chief Financial Officer, Treasurer
Jeffrey Trigilio
Chief Medical Officer
Jeffrey Jones

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$457.7M
Revenue (TTM)
$0.00
Shares Outstanding
39.3M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
---
EPS
$2.19
Book Value
$9.59
P/E Ratio
5.3x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
4.5x
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.